Foxx, Walden, Brady, Collins Introduce Legislation to Lower Drug CostsPolicy in Lower Costs, More Cures Act Has Bipartisan, Bicameral Support
WASHINGTON, D.C.,
December 9, 2019
Education and Labor Committee Republican Leader Virginia Foxx (R-NC), Energy and Commerce Committee Republican Leader Greg Walden (R-OR), Ways and Means Committee Republican Leader Kevin Brady (R-TX), and Judiciary Committee Republican Leader Doug Collins (R-GA) today released legislation - the Lower Costs, More Cures Act (H.R. 19) - to lower drug costs for Americans without limiting access to cures.
"Americans pay too much for prescription drugs and it's not right - Congress needs to step up. House Democrats and Republicans have agreed on bipartisan solutions that can become law in 2019, which will lower costs at the drug counter for patients and seniors. The Lower Costs, More Cures Act uses bipartisan reforms to lower out-of-pocket spending, protect access to new medicines and cures, strengthen transparency and accountability, and champion competition," said Foxx, Walden, Brady, and Collins. "This contains measures with bipartisan support in the House and Senate, can become law, and deserves a vote. Meanwhile, Speaker Pelosi’s partisan drug pricing scheme is not only bad policy, it’s never going to become law. We’re all here to get things done for the American people, so let’s get this done, and let’s do it now." The Lower Costs, More Cures Act:
CLICK HERE for legislative text of the Lower Costs, More Cures Act. ### |